Wiley-Blackwell
Transplanted fatty livers associated with worse prognosis for patients with HCV
Published in Blood Weekly, February 12th, 2009
A new study suggests that patients with hepatitis C (HCV) who need a liver transplant should not receive an organ with high levels of fatty deposits (a.k.a. hepatic steatosis). HCV recurrence was more frequent and earlier among those transplanted with such livers. These findings are in the January issue of Liver Transplantation, a journal published by John Wiley & Sons. The article is also available online at Wiley Interscience (www.interscience.wiley.com).
Recently, reports have revealed that survival rates among HCV-infected liver transplant recipients are decreasing. This is particularly troubling because HCV is the most common indication for liver transplantation in...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Blood Weekly
Source: Blood Weekly (2009-02-12)
More Articles from Blood Weekly
- Albert Einstein College of Medicine
Fluorescent proteins illuminating biomedical research - Alexion Pharmaceuticals, Inc.
New England Journal of Medicine Publishes Case Reports on the Investigational Use of Soliris® eculizumab in Patients with Atypical Hemolytic Uremic Syndrome aHUS - Arthritis
New arthritis study findings have been reported by J.M. Kremer and co-researchers - Autoimmune Hemolytic Anemia
Scientists at University of Sao Paulo target autoimmune hemolytic anemia - Blood Components
New blood components research has been reported by scientists at Hospital for Sick Children - Blood Substitutes
New blood substitutes findings from Ohio State University published - More from this issue of Blood Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
